Non-hospitalized Adults with COVID-19 Differ Noticeably from Hospitalized Adults in Their Demographic, Clinical, and

Sharon H Bergquist1, Clyde Partin1, David L Roberts1

  • 1Department of Medicine, Emory University, 1365 Clifton Rd, A1400, Atlanta, GA 30322 USA.

Insights

Characteristics of non-hospitalized coronavirus disease 2019 (COVID-19) patients reveal differences from hospitalized cases. This study highlights the need for broader awareness and testing for COVID-19 in ambulatory settings.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • COVID-19 (coronavirus disease 2019) characteristics are mainly known from hospitalized adults.
  • Understanding non-hospitalized COVID-19 cases is crucial for tracking its evolving epidemiology.
  • Ambulatory care data provides insights into the broader spectrum of SARS-CoV-2 (the virus that causes COVID-19) infection.

Purpose of the Study:

  • To describe the demographics, comorbidities, clinical presentation, and social factors of non-hospitalized adults with confirmed SARS-CoV-2 infection.
  • To compare the characteristics of ambulatory COVID-19 patients with those previously reported in hospitalized populations.
  • To inform public health strategies and clinical awareness regarding COVID-19 in outpatient settings.

Main Methods:

  • Retrospective medical record review of 208 SARS-CoV-2 positive patients.
  • Patients were managed in a COVID-19 virtual outpatient clinic within an academic health system.
  • Data collected included demographics, comorbidities, symptoms, social factors, and care needs.

Main Results:

  • The average age of non-hospitalized patients was 47.8 years, with 69.2% being female.
  • Nearly 70% had at least one comorbidity; common symptoms included cough (75.5%), loss of smell/taste (63%), and headache (62%).
  • Most patients experienced mild to moderate symptoms, had available caregivers, and initiated self-isolation, with care needs generally met.

Conclusions:

  • Demographic and clinical features of non-hospitalized COVID-19 patients differ significantly from hospitalized individuals.
  • Younger and seemingly healthier individuals may be at risk and warrant consideration for testing and self-isolation recommendations.
  • Social factors play a role in the effectiveness of preventive measures and resource allocation during the SARS-CoV-2 pandemic.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
1.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
121
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
583
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
71